4//SEC Filing
Feder Julie B 4
Accession 0000950170-24-006987
CIK 0001501796other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:18 PM ET
Size
5.2 KB
Accession
0000950170-24-006987
Insider Transaction Report
Form 4
Feder Julie B
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-23$7.64/sh−6,609$50,521→ 62,991 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001710237
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:18 PM ET
- Size
- 5.2 KB